Ono Venture Investment

Ono Venture Investment, Inc. (OVI) is the corporate venture capital arm of Ono Pharmaceutical Co., Ltd., an R&D-oriented pharmaceutical company that has succeeded in delivering “First in class” medicines to patients such as OPDIVO® (nivolumab). Our Mission To pursue our corporate philosophy “Dedicated to the Fight against Disease and Pain”, OVI, headquartered in the San Francisco Bay Area, one of the centers of start-up companies, is actively seeking equity-investment opportunities. Through the investments in start-up companies with outstanding ideas, assets, and technologies inthe healthcare and pharmaceutical sectors, OVI contributes to embody the ideal of the companies for their growth.